Back to Journals » Lung Cancer: Targets and Therapy » Volume 2
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Nimotuzumab, a novel monoclonal antibody to the epidermal growth factor receptor, in the treatment of non-small cell lung cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
16,620 | Dovepress* | 13,774+ | 5,077 | 18,851 | |
PubMed Central* | 2,846 | 271 | 3,117 | ||
Totals | 16,620 | 5,348 | 21,968 | ||
*Since 14 October 2011 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
5 | 0 | 0 | 0 | 0 | 5 |
View citations on PubMed Central and Google Scholar